Literature DB >> 18226624

Circulating angiogenic factors in singleton vs multiple-gestation pregnancies.

Sharon E Maynard1, Tiffany A Moore Simas, Matthew J Solitro, Abraham Rajan, Sybil Crawford, Peter Soderland, Bruce A Meyer.   

Abstract

OBJECTIVE: Placental soluble fms-like tyrosine kinase-1 may contribute to the pathogenesis of preeclampsia. Here we describe alterations in serum angiogenic factor levels in women with multiple gestation pregnancies, a major preeclampsia risk factor. STUDY
DESIGN: We collected serial serum specimens from 101 pregnant women at high preeclampsia risk between 22 and 36 weeks' gestation. Soluble fms-like tyrosine kinase-1 and placental growth factor were measured by enzyme-linked immunosorbent assay. Women who had preeclampsia or gestational hypertension develop were excluded.
RESULTS: Maternal soluble fms-like tyrosine kinase-1 was higher in multiple gestation (n = 20) compared with high-risk singleton (n = 81) pregnancies for each gestational age range examined. Maternal placental growth factor was significantly higher in multiple vs high-risk singletons before 31 weeks' gestation, whereas the soluble fms-like tyrosine kinase-1/placental growth factor ratio was higher in multiple vs high-risk singletons after 27 weeks.
CONCLUSION: Alterations in circulating angiogenic factors are present in women with multiple gestations and may contribute to higher preeclampsia risk in this population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18226624     DOI: 10.1016/j.ajog.2007.08.042

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  14 in total

1.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

Review 2.  Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.

Authors:  Sajjadh M J Ali; Raouf A Khalil
Journal:  Expert Opin Ther Targets       Date:  2015-08-17       Impact factor: 6.902

Review 3.  Angiogenic factors in preeclampsia and related disorders.

Authors:  Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

Review 4.  Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk.

Authors:  Carolina Valdiviezo; Vesna D Garovic; Pamela Ouyang
Journal:  Clin Cardiol       Date:  2012-03       Impact factor: 2.882

5.  Measurement of sVEGF R1 and PlGF in serum: comparing prototype assays from Beckman Coulter, Inc. to R&D Systems microplate assays.

Authors:  Donald Wothe; Emanuel Gaziano; Shiraz Sunderji; Roberto Romero; Juan Pedro Kusanovic; Linda Rogers; Cheryl Hodges-Savola; Sean Roberts; James Wassenberg
Journal:  Hypertens Pregnancy       Date:  2010-05-19       Impact factor: 2.108

6.  Maternal circulating angiogenic factors in twin and singleton pregnancies.

Authors:  Jessica M Faupel-Badger; Thomas F McElrath; Michele Lauria; Lauren C Houghton; Kee-Hak Lim; Samuel Parry; David Cantonwine; Gabriel Lai; S Ananth Karumanchi; Robert N Hoover; Rebecca Troisi
Journal:  Am J Obstet Gynecol       Date:  2014-11-27       Impact factor: 8.661

7.  Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies.

Authors:  Robert W Powers; Arun Jeyabalan; Rebecca G Clifton; Peter Van Dorsten; John C Hauth; Mark A Klebanoff; Marshall D Lindheimer; Baha Sibai; Mark Landon; Menachem Miodovnik
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

8.  Angiogenic and inflammatory biomarkers in midpregnancy and small-for-gestational-age outcomes in Tanzania.

Authors:  Anne Marie Darling; Chloe R McDonald; Andrea L Conroy; Kyla T Hayford; W Conrad Liles; Molin Wang; Said Aboud; Willy S Urassa; Kevin C Kain; Wafaie W Fawzi
Journal:  Am J Obstet Gynecol       Date:  2014-05-29       Impact factor: 8.661

9.  Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia.

Authors:  Sarosh Rana; Michele R Hacker; Anna Merport Modest; Saira Salahuddin; Kee-Hak Lim; Stefan Verlohren; Frank H Perschel; S Ananth Karumanchi
Journal:  Hypertension       Date:  2012-07-02       Impact factor: 10.190

10.  Hypertensive Disorders of Pregnancy and Subsequent Risk of Premature Mortality.

Authors:  Yi-Xin Wang; Mariel Arvizu; Janet W Rich-Edwards; Liang Wang; Bernard Rosner; Jennifer J Stuart; Kathryn M Rexrode; Jorge E Chavarro
Journal:  J Am Coll Cardiol       Date:  2021-03-16       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.